Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Treasury Shares (2025)

Kura Oncology (KURA) has disclosed Treasury Shares for 1 consecutive years, with $436667.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares changed N/A to $436667.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $436667.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $436667.0 for FY2025, N/A changed from the prior year.
  • Treasury Shares for Q4 2025 was $436667.0 at Kura Oncology, down from $775534.0 in the prior quarter.
  • The five-year high for Treasury Shares was $775534.0 in Q3 2025, with the low at $436667.0 in Q4 2025.